constituent of foetal serum, but it virtually disappears from the circulation very soon after birth and is not detectable in normal adults. The only conditions where cx1FP has been found in the sera of adult humans in significant quantities are primary hepatocellular cancer of the liver and teratocarcinomas. It has been shown that the demonstration of x1FP in the serum of adult patients can be regarded as a reliable indicator of the presence of primary carcinoma of the liver. Synthesis of ct,FP by liver cancer cells is believed to result from derepression of genes which had been, in turn, activated and then repressed during ontogenesis. Techniques most commonly used for the detection of a,FP are bidimensional immuinodiffusion (Ouchterlony), counter-current electrophoresis, followed by complement-fixation tests, haemagglutinin inhibition and more recently radioimmunoassay and latex agglutination. The relative merits of these techniques, as well as the problems of quantitation, standards, and availability of suitable antisera, will be discussed. The importance of good quality specific high titre antisera is emphasized. The interpretation of results and main sources of error will be considered, including the occurrence of a1FP in conditions other than hepatoma. Statistical and epidemiological data available to date regarding results obtained in various centres will be presented, as well as our own findings.
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The age range of these fatalities is of particular relevance clinically and offers a clue to the reason for the paucity of adult homozygote sicklers in this country.
The now traditional classification of crises into occlusive, haemolytic, and aplastic is meaningless in the form of the illness seen in Zambia. The clinical course of many of these fatal cases of sickle cell anaemia has been dramatic. Death occurred most commonly after a relatively short period of oligaemic shock and central cardiac failure following a rapid worsening of the anaemia, the result of acute hepatosplenic sequestration, in turn, associated with the metabolic acidosis of an infection. The key to the successful management of sickle cell anaemia is the prevention of infection.
Necropsies were performed on 21 of this series. The results further elucidate the nature of the sequestration syndrome and indicate the urgent necessity for a rational treatment regime which is simple and is proving increasingly successful. Expansion of laboratory haematology has necessitated the introduction of mechanical and automated equipment to contain the ever increasing workload. This revolution has shown the value of these machines both in terms of speed of working, numbers of tests handled, and accuracy. Further expansion is possible today and greater use of automated equipment is inevitable.
In terms of economics and availability of staff, centralization of this equipment in large, centralized laboratory areas appears inevitable. Considering the capital investment, machine potential, and the need for duplication of certain equipment, it would appear that the central laboratory should serve a population of 500,000 and receive between 500 and 1,000 tests per
